Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Kidney Transplant Recipients”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Post-approval studies (Phase 4)Study completedNCT00154297
What this trial is testing

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 139
Testing effectiveness (Phase 2)Study completedNCT02217410
What this trial is testing

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Large-scale testing (Phase 3)Study completedNCT00717678
What this trial is testing

Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationTransplantation ImmunologyHost vs Graft Reaction
Astellas Pharma Inc 73
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Large-scale testing (Phase 3)Study completedNCT01023815
What this trial is testing

Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

Who this might be right for
de Novo Kidney Transplant RecipientsRenal Transplantation
Novartis 330
Post-approval studies (Phase 4)Study completedNCT00492661
What this trial is testing

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus

Who this might be right for
Renal TransplantionKidney Transplantion
Janssen-Cilag Pty Ltd 55
Post-approval studies (Phase 4)Study completedNCT00812123
What this trial is testing

Calcineurin Free Immunosuppression in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationChronic Kidney Disease
University Hospital, Basel, Switzerland 127
Large-scale testing (Phase 3)Study completedNCT00239070
What this trial is testing

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 69
Post-approval studies (Phase 4)Study completedNCT01371331
What this trial is testing

Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Who this might be right for
Kidney TransplantationHeart TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 52
Large-scale testing (Phase 3)Study completedNCT00604357
What this trial is testing

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

Who this might be right for
End Stage Liver DiseaseImpaired Renal Function
University of Regensburg 27
Large-scale testing (Phase 3)Study completedNCT00720265
What this trial is testing

Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 135
Post-approval studies (Phase 4)Study completedNCT00862979
What this trial is testing

A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)Study completedNCT01625377
What this trial is testing

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 188
Post-approval studies (Phase 4)Study completedNCT03713645
What this trial is testing

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Temple University 36
Post-approval studies (Phase 4)Study completedNCT00238953
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 30
Post-approval studies (Phase 4)Study completedNCT00537862
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT02921789
What this trial is testing

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationPrimary Focal Segmental Glomerulosclerosis (FSGS)
Astellas Pharma Global Development, Inc. 67
Large-scale testing (Phase 3)Study completedNCT03507829
What this trial is testing

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

Who this might be right for
Hyperglycemia
Medical University of Vienna 263
Large-scale testing (Phase 3)Study completedNCT00239811
What this trial is testing

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Next Page